Open questions on bioequivalence: The case of multiple peak phenomenon

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 2, 2004, Pages 281-282

  Marzo, Antonio ^a   Reiner, Valentina ^b  

^a IPAS SA   (Switzerland)

^b APR SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DICLOFENAC POTASSIUM; PIROXICAM;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONFIDENCE INTERVAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; ENTEROHEPATIC CIRCULATION; FILM COATING; GASTROINTESTINAL TRACT; HUMAN; INTESTINE ABSORPTION; PH; STANDARD; STATISTICAL ANALYSIS; TABLET FORMULATION;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; DICLOFENAC; HUMANS; PIROXICAM; SWITZERLAND; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 1242308921     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357022656     Document Type: Article

References (13)

1. Anonymous (2001) EU note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401
2. Bettini, R., Giordano, F., Donini, C., Massimo, G., Castellani, P. L., Colombo, P. (2000) Swelling force development as a result of hydrate formation in diclofenac sodium or nitrofurantoin tablets. S.T.P. Pharm. Sci. 10: 335-339
3. Brogden, R. N., Heel, R. C., Speight, T. M., Avery, G. S. (1984) Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy. Drugs 28: 292-323
4. Chan, K. H., Mojaverian, P., Ziehmer, B. A., John, V. A. (1990) Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers. Pharm. Res. 7: 1026-1032
5. Fourtillan, J. B., Bubourg, D. (1983) Etude pharmacocinétique du piroxicam chez l'homme sain, après administration d'une dose égale à 20 mg par vole orale. Thérapie 38: 163-170
6. Macià, M. A., Frias, J., Carcas, A. J., Guerra, P., Valiente, R., Lucero, M. L. (1995) Comparative bioavailability of a dispersible formulation of diclofenac and finding of double plasma peaks. Int. J. Clin. Pharmacol. Ther. 33: 333-339
7. Marzo, A. (1995) Open questions on bioequivalence. Pharmacol. Res. 32: 237-240
8. Marzo, A. (1998) Crossover design in tamoxifen bioequivalence: a borderline situation. J. Pharm. Pharmacol. 50: 1433-1434
9. Marzo, A. (2003) Bioequivalence behind the scenes. Pharm. Dev. Reg. 1: 179-189
10. Marzo, A., Vuksic, D., Crivelli, F. (2000) Bioequivalence of endogenous substances facing homeostatic equilibria: an example with potassium. Pharmacol. Res. 42: 523-525
11. Reiner, V., Reiner, A., Reiner, G., Conti, M. (2001) Increased absorption rate of diclofenac from fast acting formulations containing its potassium salt. Arzneimittelforschung 51: 885-890
12. Terhaag, B., Gramatte, T., Hrdlcka, P., Richter, K., Feller, K. (1991) The influence of food on the absorption of diclofenac as a pure substance. Int. J. Clin. Pharmacol Ther. Toxicol. 29: 418-421
13. Terhaag, B., Hoffmann, A., Barkworth, M., Vens-Cappell, B. (2000) Bioavailability of a new effervescent tablet of diclofenac. Int. J. Clin. Pharmacol. Ther. 38: 546-551